Clinical Trials List
2026-04-17 - 2028-08-02
Phase II
Not yet recruiting4
ICD-10C22.9
Malignant neoplasm of liver, not specified as primary or secondary
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9155.2
Malignant neoplasm of liver, not specified as primary or secondary
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Chiu Hung Chiu 無
- 顏志傑 無
- Yih-Jyh Lin 無
- 劉奕廷 無
- 邱彥程 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- San-Chi Chen 無
- Yi-Ping Hung 無
- 吳啟榮 無
- 齊振達 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- YU-YUN SHAO 無
- 莊建淮 無
- TSUNG-HAO LIU 無
- Ying-Chun Shen 無
- Chiun Hsu 無
- Chih-Hung Hsu 無
- 陳柏邑 無
- 呂理駿 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
138 participants
